![](https://go.instem.com/l/864232/2023-07-28/pw76v6/864232/1690556618ebi1Ep78/AdobeStock_150353027.jpeg)
CASE STUDY
Predict™ In Silico Tox Service
Innovative Biotech Company Reduces Development Program Timelines for Neurogenerative Disease Research Program
Setting New Standards in Computational Toxicology
The client is an innovative clinical-stage drug platform company, who have a specific focus in the development of medication to treat neurogenerative diseases.
Learn how they successfully deployed Instem’s Predict™ In Silico Tox Service to significantly reduce their development program timelines.